From the Governor’s Office
Soon, the Pennsylvania Department of Health (DOH) will notify all vaccine providers to pause administering doses of the Johnson & Johnson (Janssen) vaccine until at least April 20th.
Individuals who have appointments scheduled to receive Pfizer or Moderna vaccination will be able to keep those appointments.
The Wolf Administration is taking these steps as a precaution until the Centers for Disease Control (CDC) and the Food and Drug Administration (FDA) have time to review six incidents of rare blood clots that occurred within two weeks of receiving Johnson & Johnson/Janssen vaccine. These six cases occurred in women between 18 and 48 who were among the 6.8 million Americans who received the Johnson & Johnson/Janssen vaccine. It is important to realize that this announcement shows that the federal oversight process of a vaccine’s safety and effectiveness is working and all steps are being taken to protect Pennsylvanians.
If a member of your team received the Johnson & Johnson/Janssen vaccine and has any health concerns, they should contact their health care provider. People who have received the Johnson & Johnson vaccine who develop severe headache, abdominal pain, leg pain or shortness of breath within three weeks of their vaccination should contact their health care provider. For more information, find the CDC/FDA guidance online: https://www.cdc.gov/media/releases/2021/s0413-JJ-vaccine.html.
DOH is closely monitoring the situation and will provide additional information as it becomes available from the CDC and the FDA.